Treatment of Multiple Sclerosis with Cannabis Oil

What is Multiple Sclerosis?

Multiple sclerosis is the most common chronic neurological disease affecting young adults, often diagnosed between the ages of 20 and 40. It affects women three times more often than men. Currently, there is no cure and the cause remains unknown, but it is believed that genetic and environmental factors may trigger it. In MS patients, their own immune system mistakenly attacks and damages the fatty substance around the nerves, called myelin. Myelin is like insulation around cables: if damaged, nerve signals travel more slowly or may not reach their destination at all.

This can cause a variety of symptoms, such as:

Fatigue
Numbness or tingling
Muscle weakness
Vision problems
Balance and coordination issues
Urinary tract or bladder problems

Symptoms manifest differently in everyone, so no two cases are exactly alike.

Approximately 3 million people worldwide live with multiple sclerosis. While there is no cure at present, treatments exist that help alleviate symptoms and slow the progression of the disease. So, multiple sclerosis is a complex disease that can pose serious challenges, but with proper treatment and support, many people are able to live full lives.

Multiple Sclerosis Treatment with Cannabis Oil

Cannabinoids are compounds found in cannabis that are responsible for the plant’s therapeutic effects. The two most well-known and researched cannabinoids in cannabis oils are CBD (cannabidiol) and THC (tetrahydrocannabinol), which can influence certain receptors in the brain, spinal cord, and immune system.

What Do Researchers Say?

Spasticity

Human clinical trials related to spasticity associated with multiple sclerosis show that cannabis oil may offer effective treatment.

Spasticity is an abnormal increase in muscle tone causing sustained muscle contractions and stiffness. This condition often arises from neurological issues such as multiple sclerosis, stroke, spinal cord injuries, or cerebral palsy. Spasticity can significantly impact movement, speech, and walking, as muscles involuntarily tense up, causing pain and restricted mobility. Treatment typically aims to reduce muscle tone and improve motor functions.

Seven experiments with objective measurements concluded that cannabis reduced the frequency of spasms and the associated pain in MS patients. Another recent study, reviewing evidence from 34 clinical trials, found that patients’ subjective reports of spasticity and objective measures both improved during cannabis treatment.

In the so-called CAMS clinical trial, over 600 people with multiple sclerosis used cannabis oil to manage spasticity. Ninety-five percent of these patients were in advanced stages. They reported improvements in spasticity, reduced spasticity-related pain, and better sleep quality. Participants also performed certain motor tasks more quickly.

Neuropathic Pain

Neuropathic pain presents as spontaneous burning or strong tingling sensations, which may change with temperature or touch. It can be a direct consequence of multiple sclerosis, affecting about half of those diagnosed. This type of pain often responds poorly to currently available painkillers.

Several human trials have demonstrated that cannabis can reduce neuropathic pain in people with multiple sclerosis. One such clinical trial found that among those who did not respond to traditional painkillers, pain perception scores were lower after 10 weeks of treatment with Sativex.
(Sativex is a medication containing two active cannabinoids, THC and CBD, in a 1:1 ratio. It is typically administered as a spray applied to the oral mucosa.)
The study also noted that the pain-relieving effect disappeared once participants stopped using Sativex.

It’s important to highlight that Sativex contains only two of the many cannabinoids found in full-spectrum oils, which scientifically work synergistically to enhance each other’s effects, each contributing significant therapeutic properties on its own.

Urinary Tract or Bladder Problems

People with multiple sclerosis may experience urinary tract or bladder issues. These symptoms are often not reported to healthcare professionals but can have serious long-term consequences. So far, few studies have examined whether cannabis oil can influence urinary problems in MS patients. Analysis of data from the previously mentioned CAMS study and a few smaller studies found that cannabis oil improved many urinary problems, including the frequency and number of daytime and nighttime incontinence episodes. Participants also reported improvements in these types of symptoms themselves.

What Type of Cannabis Oil Should I Use?

There are two main types of cannabis oils: full-spectrum and broad-spectrum. The key difference is that full-spectrum cannabis oil contains THC, while broad-spectrum does not.
Based on current research findings, it is advisable to choose a cannabis oil containing THC for treating multiple sclerosis—i.e., a full-spectrum product.

Choose a preparation that, alongside CBD and THC, contains as many valuable compounds from the cannabis plant as possible!
All responsible distributors make cannabinoid analysis easily accessible, showing the list of cannabinoids in the product. So select a full-spectrum preparation that also contains at least CBDA, CBC, CBN, and CBG, to achieve the best possible effect.

How Much Cannabis Oil Should I Use?

The amount of cannabis oil used for multiple sclerosis treatment varies by individual and depends on factors such as disease severity and personal tolerance. Because dosing and usage can differ widely, it’s important to start with a low dose and gradually increase it while monitoring your body’s reactions and symptom relief.

You can find a comprehensive dosing guide on our website here: https://www.cannadolcbd.eu/hu/cbd-adagolasi-utmutato